calcimimetic

Any drug that acts like calcium, for example, that lowers serum parathyroid hormone levels.

calcimimetic

Of any drug that increases activation of CALCIUM-SENSING RECEPTORS. Calcimimetics show promise in the treatment of hyperparathyroid states. Compare CALCILYTIC.

Mentioned in ?

References in periodicals archive ?

2014) The odds of using phosphate binders, intravenous vitamin D analogs, and calcimimetic are higher among patients with low-income subsidies (OR = 1.

Medicare Part D's effects on drug utilization and out-of-pocket costs: A systematic review

Strontium is a calcimimetic that blocks calcium ion channels.

Strontium, ketamine target troublesome itch

In an appraisal consultation document, the National Institute for Health and Care Excellence (NICE) has recommended Amgen's (NASDAQ: AMGN) Parsabiv (etelcalcetide) to treat secondary hyperparathyroidism (sHPT), if treatment with a calcimimetic is indicated but cinacalcet is not suitable, and as long as the company provides the drug with the discount agreed in the patient access scheme, Pharma Times reported on Tuesday.

NICE backs use of Amgen's Parsabiv to treat secondary hyperparathyroidism

If approved, Parsabiv will be the first calcimimetic agent that can be administered intravenously by a healthcare provider three times a week at the end of a hemodialysis session.

United States : Amgen Receives Positive CHMP Opinion For Parsabiv (Etelcalcetide) For The Treatment Of Secondary Hyperparathyroidism In Adult Patients With Chronic Kidney Disease On Hemodialysis

Furthermore, only 2 patients were receiving cinacalcet, a calcimimetic agent, to decrease PTH and calcium levels.

Longitudinal observations on the mineral metabolism of dialysis patients at the University Hospital

Parathyroidectomy may now be necessary or expensive calcimimetic drugs must be administered to try to restore the disordered metabolic environment.

Important complications of chronic kidney disease

A calcimimetic (cinacalcet) is a new type of drug to be considered as a potential therapy for some people with severe hypercalcemia and primary hyperparathyroidism who are unable to undergo parathyroidectomy and for secondary hyperparathyroidism on dialysis.

Parathyroid adenoma presenting as primary hyperparathyroidism

Cinacalcet, a calcimimetic for control of hypercalcemia and secondary hyperparathyroidism, was also started.

Calciphylaxis: a devastating complication of derangements of calcium-phosphorus metabolism--a case report and review of the literature

Calcimimetic agents act as an allosteric modulator, imitating the properties of extracellular calcium activating the calcium-sensitive receptor on parathyroid cells.

32-year-old male with parathyroid carcinoma

Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and healthrelated quality of life in secondary hyperparathyroidism.

The patients with primary hyperparathyroidism: evaluation of the last two years / Primer Hiperparatiroidili Hastalarimiz: Son iki Yilin Degerlendirmesi

Cinacalcet is a calcimimetic drug, which lowers PTH without increasing calcium or phosphorus.

Update on the new Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for mineral and bone disorders (MBD)--a focus on medications

This finding diametrically changes the treatment strategy to controlling the effects of CKD on the cardiovascular system by decreasing the serum phosphorus and on the PTH concentration by using a calcimimetic agent, because the presence of hypercalcemia contraindicates increasing the dose of vitamin D analogs.

A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations

CITE

Site: Follow: Share:

Open / Close